Total Funding
53
58
Total FundingGrant raised
Growth Score
-8 pts
Heat Score
-1 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Events
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
48410
Brixton Biosciences is a clinical-stage life sciences company that develops therapies for chronic and acute pain.
- R. Rox Anderson: Co-Founder
- Lilit Garibyan: Co-Founder
About the Company
Brixton Biosciences is a clinical-stage life sciences company developing novel therapies for pain treatment. Backed by deep research, the company addresses crucial unmet needs in pain management, which has historically been dominated by systemic medicine. Brixton Biosciences' innovative therapeutics, such as its novel Neural Ice™, provide pain
relief in a single, safe, and easy drug-free injectable that is a non-addictive, locally targeted, and comparatively long-lasting solution.
